Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oncogene alterations in non-small cell lung cancer-have we MET a new target? | Transl Lung Cancer Res | 2022 | 36386451 | PubTator, text mining | PubMed |
| Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia. | Exp Hematol Oncol | 2022 | 36384590 | PubTator, text mining | PubMed |
| CommPath: An R package for inference and analysis of pathway-mediated cell-cell communication chain from single-cell transcriptomics. | Comput Struct Biotechnol J | 2022 | 36382188 | PubTator, text mining | PubMed |
| Determination of temporal reproducibility and variability of cancer biomarkers in serum and EDTA plasma samples using a proximity extension assay. | Clin Proteomics | 2022 | 36376783 | PubTator, text mining | PubMed |
| B cells in human lymphoid structures. | Clin Exp Immunol | 2022 | 36370126 | PubTator, text mining | PubMed |
| The employment of vaccinia virus for colorectal cancer treatment: A review of preclinical and clinical studies. | Hum Vaccin Immunother | 2022 | 36369829 | PubTator, text mining | PubMed |
| Cytomegalovirus infection reduced CD70 expression, signaling and expansion of viral specific memory CD8+ T cells in healthy human adults. | Immun Ageing | 2022 | 36368988 | PubTator, text mining | PubMed |
| Migratory Engineering of T Cells for Cancer Therapy. | Vaccines (Basel) | 2022 | 36366354 | PubTator, text mining | PubMed |
| Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy. | Int J Mol Sci | 2022 | 36362027 | PubTator, text mining | PubMed |
| Deregulated Expression of Circular RNAs Is Associated with Immune Evasion and Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. | Genes (Basel) | 2022 | 36360223 | PubTator, text mining | PubMed |
| Nanoparticle Enhancement of Natural Killer (NK) Cell-Based Immunotherapy. | Cancers (Basel) | 2022 | 36358857 | PubTator, text mining | PubMed |
| The Proliferative Role of Immune Checkpoints in Tumors: Double Regulation. | Cancers (Basel) | 2022 | 36358792 | PubTator, text mining | PubMed |
| Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarcinoma. | Pharmaceuticals (Basel) | 2022 | 36355508 | PubTator, text mining | PubMed |
| Genome-Wide Gene Expression Analysis Reveals Unique Genes Signatures of Epithelial Reorganization in Primary Airway Epithelium Induced by Type-I, -II and -III Interferons. | Biosensors (Basel) | 2022 | 36354438 | PubTator, text mining | PubMed |
| Natural killer cells in clinical development as non-engineered, engineered, and combination therapies. | J Hematol Oncol | 2022 | 36348457 | PubTator, text mining | PubMed |
| Advances in CAR T-cell therapy in bile duct, pancreatic, and gastric cancers. | Front Immunol | 2022 | 36341440 | PubTator, text mining | PubMed |
| The immune factors have complex causal regulation effects on bone mineral density. | Front Immunol | 2022 | 36341399 | PubTator, text mining | PubMed |
| The role of T-cells in head and neck squamous cell carcinoma: From immunity to immunotherapy. | Front Oncol | 2022 | 36338731 | PubTator, text mining | PubMed |
| An improved Fuzzy based GWO algorithm for predicting the potential host receptor of COVID-19 infection. | Comput Biol Med | 2022 | 36334362 | PubTator, text mining | PubMed |
| Progress in the application of body fluid and tissue level mRNAs-non-coding RNAs for the early diagnosis and prognostic evaluation of systemic lupus erythematosus. | Front Immunol | 2022 | 36325322 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=55